Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Back for the new year, here are the editors’ selections for the January issues of the eight scientific journals...
At long last, cancer survival statistics are beginning to reveal real progress. From 1991 to 2015, the cancer death...
In the final weeks of 2018, the U.S. Food and Drug Administration (FDA) announced three approvals of anticancer therapeutics....
January is Cervical Cancer Awareness Month. Given that January was named after the Roman god Janus, whose two faces...
In addition to world-class training in patient care, physician-scientists also require experience in laboratory and clinic-based research to ensure...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors' Picks, a monthly...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...